Your browser doesn't support javascript.
An Overview on the Potential Roles of EGCG in the Treatment of COVID-19 Infection.
Bimonte, Sabrina; Forte, Cira Antonietta; Cuomo, Massimiliano; Esposito, Gennaro; Cascella, Marco; Cuomo, Arturo.
  • Bimonte S; Division of Anesthesia and Pain Medicine, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.
  • Forte CA; Division of Anesthesia and Pain Medicine, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.
  • Cuomo M; S.C. Project Management e Formazione, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.
  • Esposito G; Division of Anesthesia and Pain Medicine, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.
  • Cascella M; Division of Anesthesia and Pain Medicine, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.
  • Cuomo A; Division of Anesthesia and Pain Medicine, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.
Drug Des Devel Ther ; 15: 4447-4454, 2021.
Article in English | MEDLINE | ID: covidwho-1502185
ABSTRACT
Coronavirus disease-19 (COVID-19) pandemic is currently ongoing worldwide and causes a lot of deaths in many countries. Although different vaccines for the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection have been developed and are now available, there are no effective antiviral drugs to treat the disease, except for Remdesivir authorized by the US FDA to counteract the emergency. Thus, it can be useful to find alternative therapies based on the employment of natural compounds, with antiviral features, to circumvent SARS-CoV-2 infection. Pre-clinical studies highlighted the antiviral activities of epigallocatechin-3-gallate (EGCG), a catechin primarily found in green tea, against various viruses, including SARS-CoV-2. In this review, we summarize this experimental evidence and highlight the potential use of EGCG as an alternative therapeutic choice for the treatment of SARS-CoV-2 infection.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Catechin / COVID-19 Drug Treatment Type of study: Prognostic study Topics: Traditional medicine / Vaccines Limits: Humans Language: English Journal: Drug Des Devel Ther Journal subject: Pharmacology / Drug Therapy Year: 2021 Document Type: Article Affiliation country: DDDT.S314666

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Catechin / COVID-19 Drug Treatment Type of study: Prognostic study Topics: Traditional medicine / Vaccines Limits: Humans Language: English Journal: Drug Des Devel Ther Journal subject: Pharmacology / Drug Therapy Year: 2021 Document Type: Article Affiliation country: DDDT.S314666